The phrase "counter virus" is correct and can be used in written English.
You can use it when referring to a type of computer software that is designed to detect, prevent, and remove computer viruses. For example, "I've installed a counter virus software on my computer to protect it from malicious attacks."
Therefore, the change in antiviral activities between duplicated Tetherins in ruminants may be attributed to some viral infections, and the duplicated copies with increasing antiviral ability may serve as host strategy to counter virus infection.
Interestingly, results obtained from present study indicated that NF90 protein has the ability to counter the effect of HCV core protein mediated RANTES expression in both cell types examined, suggesting its ability to counter virus mediated effect on host cell antiviral response.
She joined Iversen, and others in the lab, to create, test, and modify antisense compounds to counter viruses, including Ebola and Marburg.
The release of a counter-virus, cultivated to destroy the virus' avian carriers in a desperate attempt to stop the spread of the disease, ends up backfiring as birds who resisted the counter-virus instead developed human-level intelligence.
The health agency said at the time that "a specific treatment or vaccine would be a potent asset to counter the virus".
These results support the idea that although individual miRNAs can act to restrict HIV-1 replication, the virus does not counter these effects through a global suppression of RNAi synthesis or processing.
As a counter-defense, viruses encode RNA silencing suppressors (RSSs) that act to suppress the RNA silencing machinery [ 9].
Protein Sciences Corporation and Baylor College of Medicine analyzed the samples by plaque assay and InDevR analyzed the samples using the Virus Counter.
Direct log-scale comparison between pooled Virus Counter results and pooled plaque assay results indicated a linear relationship (slope = 1.1 ± 0.2, R2 = 0.86) with statistically significant Pearson correlation (r = 0.93, p < 0.001).
But while the vaccine had 100percentt efficacy among the nearly 6,000 test subjects in Guinea who received it, NPR notes those numbers will likely decline over time as more people are vaccinated, and more work is likely needed to craft a "perfect" counter to the virus.
These findings provide new insight on the molecular arms race between host antiviral defense and virus counter defense at an epigenetic level.
